Showing results (11-20 of 44) with videos related to
Sort By:
Pageof 5
Plos One|December 31, 2013
Proof of the concept to use a malignant B cell line drug screen strategy for identification and weight of melphalan resistance genes in multiple myelomaMartin Bøgsted, Anders E Bilgrau, Christopher P Wardell, et al.Blood|February 26, 2013
Characterization of IGH locus breakpoints in multiple myeloma indicates a subset of translocations appear to occur in pregerminal center B cellsBrian A Walker, Christopher P Wardell, David C Johnson, et al.Plos One|March 10, 2012
A modified method for whole exome resequencing from minimal amounts of starting DNAIwanka Kozarewa, Juan Manuel Rosa-Rosa, Christopher P Wardell, et al.Blood|May 11, 2012
Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myelomaBrian A Walker, Christopher P Wardell, Lorenzo Melchor, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 18, 2011
Gender disparities in the tumor genetics and clinical outcome of multiple myelomaKevin D Boyd, Fiona M Ross, Laura Chiecchio, et al.Plos One|June 14, 2014
A novel functional role for MMSET in RNA processing based on the link between the REIIBP isoform and its interaction with the SMN complexFabio Mirabella, Alexander Murison, Lauren I Aronson, et al.European Journal of Haematology|May 10, 2016
Genomewide profiling of copy-number alteration in monoclonal gammopathy of undetermined significanceAneta Mikulasova, Jan Smetana, Marketa Wayhelova, et al.Oncotarget|April 14, 2017
Search for rare protein altering variants influencing susceptibility to multiple myelomaMatthew Scales, Daniel Chubb, Sara E Dobbins, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2011
Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survivalKevin D Boyd, Fiona M Ross, Brian A Walker, et al.Blood Cancer Journal|May 31, 2022
Structural variants shape the genomic landscape and clinical outcome of multiple myelomaCody Ashby, Eileen M Boyle, Michael A Bauer, et al.Pageof 5